Filana Therapeutics Files 8‑K Announcing Results of Operations

What Happened
Filana Therapeutics, Inc. (FLNA) issued a press release on July 29, 2026 reporting its results of operations and financial condition. The company furnished the press release as Exhibit 99.1 to a Form 8‑K (Item 2.02). The filing states the information is being furnished — not “filed” — and therefore is not subject to Section 18 liability or automatic incorporation by reference into other SEC filings.

Key Details

• Filing date: July 29, 2026; Item reported: 2.02 (Results of Operations and Financial Condition).
• Exhibit: 99.1 — Press Release dated July 29, 2026 attached to the 8‑K.
• The disclosure is furnished (not filed), and the company notes it should not be deemed filed for Section 18 liability purposes.
• The filing also references an Inline XBRL cover page interactive data file.

Why It Matters
This 8‑K signals that Filana published updated financial results (earnings, revenue, cash position or related metrics) via a press release on July 29, 2026. Investors should read the attached press release for the specific numbers and context (e.g., revenue, net income/loss, cash runway, or any management commentary). Because the information is furnished rather than filed, it carries the company’s disclosure but is not subject to the same SEC liability provisions as filed reports; investors should still rely on subsequent filed reports (10‑Q/10‑K) for formally incorporated financial statements and detailed accounting disclosures.